key: cord-0928904-npq0pe2j authors: Scarpa, A; Ralli, M; De Bonis, E; Troisi, D; Montanino, A; Viola, P; Chiarella, G; Gioacchini, FM; Cavaliere, M; Cassandro, E; Cassandro, C title: Pharmacological, surgical and diagnostic innovations in Meniere’s disease: a review date: 2020-10-01 journal: Transl Med UniSa DOI: 10.37825/2239-9747.1009 sha: 67603dd412627d4a290b0806550f017f82dbc8e9 doc_id: 928904 cord_uid: npq0pe2j Meniere’s disease is an inner ear disorder characterized by the presence of endolymphatic hydrops in the inner ear and symptomatology of recurrent and debilitating vertigo attacks, tinnitus, aural fullness, and fluctuating sensorineural hearing loss. Although many therapeutic options for MD have been proposed during years, no consensus has been reached by the scientific community. In the last decade, many therapeutic options have been proposed, as intratympanic steroid, intratympanic gentamicin, and intravenous glycerol. Recently, the role of the antisecretory factor in the diet of MD patients have been investigated. Surgery is recommended for intractable MD; some authors proposed new approaches including transcanal endoscopic infracochlear vestibular neurectomy, new marsupiliazation technique in sac surgery, and tenotomy of the stapedius and tensor tympani muscles. Meniere disease (MD) is an inner ear disorder characterized by the presence of endolymphatic hydrops (EH) in the inner ear and symptomatology of recurrent and debilitating vertigo attacks, tinnitus, aural fullness, and fluctuating sensorineural hearing loss (SNHL) 1, 2, 3 . Although hearing loss is mainly sensorineural, lowfrequency air-bone gap (ABG) can also be found in the absence of middle ear pathology 4 , mimicking other conditions such as cerebral vascular anomalies including dural arteriovenous fistula 5 . MD symptoms can severely affect the quality of life 6, 7 . Although many therapeutic options for MD have been proposed, no consensus has been reached by the scientific community [8] [9] [10] [11] . First-line treatment includes dietary restrictions for salt, caffeine, and alcohol associated to drugs both for acute attacks (dimenhydrinate, benzodiazepines) 12 , and as prophylactic therapy (betahistine, β-blockers, diuretics) 13 . When first-line treatment does not offer satisfactory symptom control, intratympanic (IT) administration of gentamicin or corticosteroids can be performed 14 ; however, many studies showed that IT gentamicin may expose the patients to a risk of hearing loss, depending on dosage and intervals between administrations 15 . Labyrinthectomy or other surgical procedures can be suggested for intractable MD 16 . Despite the recent COVID-19 pandemic 17-20 , scientific research for MD is a growing area in continuous development. This brief review aims to assess the clinical innovations for the therapy of MD. The main goal of the pharmacological treatment of MD is to reduce the duration and frequency of vertigo attacks, and to prevent hearing loss, which is usually progressive. 27 proposed a low-dose IT gentamicin protocol; they treated 48 patients with 0.5 ml of 10 mg of gentamicin with an interval of 2 weeks between injections. They reported a satisfactory control of vertigo attacks after IT gentamicin, and the effect of this protocol on vestibular system was proved by the reduction in vestibulo-ocular reflex (VOR) gain in the affected side. A meta-analysis from Jian et al 28 demonstrated that IT gentamicin is superior to IT steroids in reducing the number of vertigo attacks, but both drugs didn't show hearing improvement. Moreover, Ozturk and Ata proposed an IT mixture of gentamicin and dexamethasone injection for the treatment of intractable MD, even more effective that IT dexamethasone for vertigo control 29 . Diuretics have also been recommended to control vertigo attacks in MD, due to their effects in reducing the endolymphatic pressure and volume. As for steroids and gentamicin, there are no high-quality data demonstrating the efficacy of oral diuretic therapy 30 ; in addition, a metaanalysis from Rosenbaum and Winter 31 concluded that it is not clear if diuretic lead to a symptomatic improvement of vertigo. A prospective study from Scarpa et al 32 evaluated the effectiveness on vertigo control of intravenous (IV) glycerol (an osmotic diuretic), 10% glycerol with 0.9% sodium chloride, 0.5 g/kg once a day for 2 consecutive days every fifteen days for six months; the authors reported an improvement of vertigo attacks and a significant reduction of discomfort generated by tinnitus, raising quality of life. Recently, some authors suggested a possible action of antisecretory factor (AF), a protein produced by pituitary gland that plays a role in the innate defense against the inflammatory and secretory components of diarrheal disease 33 . It has been hypothesized that AF can act as a modulator of water and ions and interact with the aquaporins. Viola et al 34 observed a significant improvement in daily activities in patients treated with specially processed cereals (SPC) compared to those treated with IV glycerol and dexamethasone. The study reported a significant reduction of vertigo spells and a positive effect on tinnitus severity. According to international guidelines, surgical therapy for MD is recommended only for refractory disease, and therefore represents the third (or even the fifth) line of management. Currently, the most popular surgical procedures to control vertigo attacks in MD are also the most aggressive and those that have the most negative impact on auditory function. Besides, there is a lack of evidence suggesting that surgical therapy for MD may provide a significant control of symptoms 35 . The table below shows the main surgical procedures for MD taking into account of hearing preservation, vestibular injury, surgical difficulty and long-term outcomes ( Table 1) . Endolymphatic sac surgery (ESS) can be considered in patients that are refractory to medical management as a nondestructive option, as the risk to damage hearing is low 36 . Xu et al 37 suggested that ESS with posterior tympanotomy and local steroid treatment could improve hearing and ensure a satisfactory vertigo control in patients with intractable MD. In Gibson et al opinion 38 , ESS can provide a vertigo control at least as well as IT gentamicin with a lower incidence of audio-vestibular complications 39 . Transmastoid labyrinthectomy alone 40 More recently, some authors suggested that tenotomy of the stapedius and tensor tympani muscles (TSTM) may be a safe surgical procedure with significant vertigo control, decreased postoperative symptoms and important hearing preservation 46 . In the diagnosis and the evaluation of therapy efficacy, the audio-vestibular test battery has a primary role, and the diagnostic findings are constantly evolving. 49 . Patients with suspected MD can be examined using magnetic resonance imaging (MRI) to evaluate a possible inner ear disease. The MRI findings in patients with MD are conflicting, due to the MRI sequences used and the inclusion criteria of the patients; also, the early stage of MD and the early symptoms appear too subtle for identification using MRI, making the reproducibility of hydrops MRI scan protocols debatable 50 . Despite accumulating evidence for the treatment of MD, there is currently no international consensus on a standardized therapeutic protocol for this condition. Intravenous administration of glycerol, low-dose intratympanic gentamicin, and antisecretory factor are promising innovations. The role of surgery in the treatment of MD is still debated; recent techniques as tenotomy of the stapedius and tensor tympani muscles seems to offer interesting insights, but larger randomized studies are needed to draw conclusions. Recurrence of Non-Hydropic Sensorineural Hearing Loss (SSNHL): a literature review Hyperglycemia and diabetes mellitus are related to vestibular organs dysfunction: truth or suggestion? A literature review Equilibrium Committee Amendment to the 1995 AAO-HNS Guidelines for the Definition of Meniere's Disease. Otolaryngol Head Neck Surg Inner-Ear Disorders Presenting with Air-Bone Gaps: A Review Inner Ear Conductive Hearing Loss and Unilateral Pulsatile Tinnitus Associated with a Dural Arteriovenous Fistula: Case Based Review and Analysis of Relationship between Intracranial Vascular Abnormalities and Inner Ear Fluids Diagnostic criteria for Meniere's disease SCORE risk scale as a prognostic factor after sudden sensorineural hearing loss Assessment Tools for Use in Patients with Meniere Disease: An Update What is Meniere's disease? A contemporary re-evaluation of endolymphatic hydrops Therapeutic strategies in the treatment of Menière's disease: the Italian experience Letter to Editor concerning the "Therapeutic strategies in the treatment of Meniere's disease: the Italian Experience Intratympanic corticosteroids in Meniere's disease: A mini-review Dietary Restriction for The Treatment of Meniere's Disease Intratympanic (IT) Therapies for Meniere's Disease: Some Consensus Among the Confusion Intratympanic Therapies in Meniere Disease: Evaluation of Outcomes and Early Vertigo Control Surgical management of intractable Meniere's disease COVID-19 Pandemic and Head and Neck Surgery Residency Program: Proposals for the "Phase 2 Impact of the COVID-19 Pandemic on Otolaryngology Residency: A Real-Life Experience Nasal, pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies Chloroquine and Hydroxychloroquine Ototoxicity; Potential Implications for SARS-CoV-2 Treatment. A Brief Review of the Literature Intratympanic steroid for Meniere's Disease Long Term Outcomes of Intratympanic Dexamethasone in Intractable Unilateral Meniere's Disease Control of vertigo in Ménière's disease by intratympanic dexamethasone Long-Term Follow-Up of Intratympanic Methylprednisolone Versus Gentamicin in Patients With Unilateral Menière's Disease Effectiveness of intratympanic administration of gentamicin Letter to the Editor: Intratympanic gentamicin for Ménière's disease: is there a selective vestibulotoxic effect? Low-dose intratympanic gentamicin administration for unilateral Meniere's disease using a method based on clinical symptomatology: Preliminary results What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere's disease compared with steroids? A meta-analysis Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease Are diuretics useful in the treatment of meniere disease? Laryngoscope Are diuretics effective for Meniere's disease? Mewave Therapeutic role of intravenous glycerol for Meniere's disease. Preliminary results Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere's disease: our results The role of endogenous Antisecretory Factor (AF) in the treatment of Ménière's Disease: A two-year follow-up study. Preliminary results Current state of evidence for endolymphatic sac surgery in Menière's disease: a systematic review Is Endolymphatic Sac Surgery Beneficial For Meniere's Disease? Effects of endolymphatic sac decompression combined with posterior tympanotomy with local steroids for intractable Meniere's disease A comparison of endolymphatic shunt surgery and intratympanic gentamicin for meniere's disease Sub-Clinical Effects of Chronic Noise Exposure on Vestibular System Transmastoid Labyrinthectomy for Menière's Disease: Experience and Outcomes Surgical Labyrinthectomy and Cochlear Implantation in Menière's Disease Menière's disease treated by grommet insertion Long-term outcomes of triple semicircular canal plugging for the treatment of intractable Meniere's disease: A single center experience of 361 cases New marsupialization technique in endolymphatic sac surgery. laryngoscope Investig Otolaryngol Transcanal endoscopic infracochlear vestibular neurectomy: A pilot cadaveric study Endolymphatic sac surgery versus tenotomy of the stapedius and tensor tympani muscles in the management of patients with unilateral definite Meniere's disease Head-Shaking Nystagmus in the Early Stage of Unilateral Meniere's Disease Evolution in the Findings of Head-Impulse Tests During the Attacks of Menière's Disease Dissociation of caloric and head impulse tests: a marker of Meniere's disease Systematic review of magnetic resonance imaging for diagnosis of Meniere disease Criteria for the Declaration of Death Making Sense of the Chest x-ray: a Handson guide